Short bowel syndrome epidemiology and demographics

Revision as of 17:15, 22 November 2017 by Ssharfaei (talk | contribs)
Jump to navigation Jump to search

Short bowel syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Short bowel syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Short bowel syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Short bowel syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Short bowel syndrome epidemiology and demographics

CDC on Short bowel syndrome epidemiology and demographics

Short bowel syndrome epidemiology and demographics in the news

Blogs on Short bowel syndrome epidemiology and demographics

Directions to Hospitals Treating Short bowel syndrome

Risk calculators and risk factors for Short bowel syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

Epidemiology and Demographics

Incidence

  • The incidence and prevalence of short bowel syndrome is difficult to estimate. Data is derived from patients receiving home parenteral nutrition.[1]
  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

Prevalence

  • The prevalence of short bowel syndrome is approximately 0.3-0.4 per 100,000 individuals in the USA.[2]
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
  • The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Patients of all age groups, from neonates to elderly may develop short bowel syndrome.

Race

  • There is no racial predilection to short bowel syndrome.

Gender

  • Short bowel syndrome affects men and women equally.

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

References

  1. Bechtold, Matthew L.; McClave, Stephen A.; Palmer, Lena B.; Nguyen, Douglas L.; Urben, Lindsay M.; Martindale, Robert G.; Hurt, Ryan T. (2014). "The Pharmacologic Treatment of Short Bowel Syndrome: New Tricks and Novel Agents". Current Gastroenterology Reports. 16 (7). doi:10.1007/s11894-014-0392-2. ISSN 1522-8037.
  2. Seetharam P, Rodrigues G (2011). "Short bowel syndrome: a review of management options". Saudi J Gastroenterol. 17 (4): 229–35. doi:10.4103/1319-3767.82573. PMC 3133978. PMID 21727727.

Template:WH Template:WS